SEC Form 4 · accession 0001645470-19-000004
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 15, 2019
Accepted (ET)
Jan 18, 2019 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0296 | A | 20,651,123 | D | |
| Common Stock | Jan 15, 2019 | P | 2,500 | $0.0292 | A | 20,653,623 | D | |
| Common Stock | Jan 15, 2019 | P | 10,000 | $0.0319 | A | 20,663,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0332 | A | 20,668,623 | D | |
| Common Stock | Jan 15, 2019 | P | 10,000 | $0.0335 | A | 20,678,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0332 | A | 20,683,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0332 | A | 20,688,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0335 | A | 20,693,623 | D | |
| Common Stock | Jan 15, 2019 | P | 2,000 | $0.0332 | A | 20,695,623 | D | |
| Common Stock | Jan 15, 2019 | P | 2,000 | $0.0327 | A | 20,697,623 | D | |
| Common Stock | Jan 15, 2019 | P | 10,000 | $0.0328 | A | 20,707,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.033 | A | 20,712,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0309 | A | 20,717,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.031 | A | 20,722,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0328 | A | 20,727,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.032 | A | 20,732,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0319 | A | 20,737,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0308 | A | 20,742,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.0298 | A | 20,747,623 | D | |
| Common Stock | Jan 15, 2019 | P | 10,000 | $0.03 | A | 20,757,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.03 | A | 20,762,623 | D | |
| Common Stock | Jan 15, 2019 | P | 5,000 | $0.03 | A | 20,767,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.0304 | A | 20,772,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.0306 | A | 20,777,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.031 | A | 20,782,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.0296 | A | 20,787,623 | D | |
| Common Stock | Jan 16, 2019 | P | 10,000 | $0.0294 | A | 20,797,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.0293 | A | 20,802,623 | D | |
| Common Stock | Jan 16, 2019 | P | 5,000 | $0.0293 | A | 20,807,623 | D |
Table II — derivative securities
No Table II lines on this filing.